Revive will bring Bucillamine to wherever there is a need. The Indian government does not require an FDA approval to buy Bucillamine, and they are aware of its safety ratings, so why not get a head start in setting up a manufacturing pipeline? Revive still is planning to apply for EUA and seek FDA approval. Nothing has changed (except for a few new variants that Bucillamine needs to eradicate).
In a global pandemic there is use for Bucillamine all over the world and not just in the USA with the fda. Revive can then use the money from the India route to hopefully purchase a few other psychedelic companies is my hope (just like the Marijuana companies consolidated).
News 
Market Data 
Discover 
AI
